Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2

Conditions

Neoplasms, Plasma Cell 3Neoplasms 2Multiple Myeloma 2Lymphoma 2Leukemia 2Infections 2Lymphoma, Non-Hodgkin 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Neoplasms 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7Ciprofloxacin 5gamma-Globulins 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Trimethoprim 2Sulfamethoxazole 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Moxifloxacin 2Melphalan 2Itraconazole 2Immunoglobulins, Intravenous 2Cyclophosphamide 2Caspofungin 2talquetamab 1idecabtagene vicleucel 1fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Voriconazole 1Vancomycin 1Valacyclovir 1Therapeutics 1Tazobactam 1Tacrolimus 1Sodium Chloride 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Infections × Immunoglobulins, Intravenous × Plasma cell × Clear all
NCT07202052 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms, Plasma Cell

NCT07202065 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡